Mar 14, 2017 - Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells DexCom, Aerie Pharmaceuticals, Depomed, Stocks: NBIX,ACRS,FOLD,ANIP,AVXS,GBT,GLPG,AVDL,ACOR,IRTC,C, release date:Mar 14, 2017
Mar 14, 2017 - Novartis AG (NVS) announced that the FDA has approved Kisqali, for use in combination with an aromatase inhibitor for the first-line treatment of postmenopausal women with hormone receptor positive, HR+/HER2- advanced or metastatic breast cancer.
Mar 13, 2017 - Aerie Pharmaceuticals is a development-stage company focused on the development and commercialization of eye disease therapies, including glaucoma and other eye-diseases.
Mar 10, 2017 - Incyte (INCY) tops the list of stocks that enjoyed a stupendous run in the last 8 years.
Mar 09, 2017 - Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells DexCom, Aerie Pharmaceuticals, Depomed, Stocks: NBIX,ACRS,FOLD,ANIP,AVXS,GBT,GLPG,AVDL,ACOR,IRTC,C, release date:Mar 09, 2017
Mar 09, 2017 - AMG Advanced Metallurgical Group NV (OTCPK:AMVMF): Q4 EPS of $0.32Revenue of $237.87M (+7.7% Y/Y)Press Release
Mar 08, 2017 - President Donald Trump March 7 tweet on increasing competition and lowering drug prices sent fresh shockwaves across the industry.
Mar 08, 2017 - Eli Lilly and Company (LLY) announced superior efficacy in a head-to-head study evaluating its marketed drug, Taltz (ixekizumab) versus with Johnson & Johnson???s Stelara (ustekinumab) in patients with moderate-to-severe plaque.
Mar 06, 2017 - David Winters Comments on Heineken Holding NV, Stocks: XAMS:HEIO, David Winters, release date:Mar 06, 2017
Mar 03, 2017 - The following slide deck was published by Gemalto NV in conjunction with their 2016 Q4 earnings call.